Embleema’s leadership team brings together more than 100 years of industry experience in life sciences, healthcare data, wearable, digital health & Blockchain technology across the US, Europe & Asia-Pacific.
Core Team
Robert Chu
Recognizing the considerable potential of cloud and blockchain technologies in the healthcare industry and the need for better solves for care continuum and pervasive cyber-security issues, Robert founded Embleema in 2017 after a distinguished career at IBM and [...]
Nicolas Schmidt
Nicolas is Chief Product Officer at Embleema. He focuses on building innovations that help patients regain control of their health data and share them transparently with research organizations. He is also co-chair of the Mobile Health Applications Working Group at[...]
Vahan Simonyan, PhD
Dr. Vahan Simonyan has a solid scientific background in varied academic disciplines: MS in Physical Organic Chemistry, Ph.D. in Quantum Physics and Mathematics, post-doctoral training in Nanotechnology and Quantum Statistical Thermodynamics. After 2001, he switched his expertise to biotechnology and[...]
Sophie Martineau
Brittany Sorice
Advisors
Pascale Witz
Pascale Witz, MBA, is a Molecular Biologist and an Engineer; a global Pharmaceutical, MedTech and Diagnostics Executive, with 30 years’ experience leading businesses in the US and globally; a board member of public and private Life Science companies; an advisor to CEOs and
Pr. John Halamka, MD
John D. Halamka, MD, MS, is a Professor of Medicine at Harvard Medical School, Chief Information Officer of Beth Israel Deaconess Medical Center, Chairman of the New England Healthcare Exchange Network (NEHEN), co-Chair of the national HIT Standards Committee, co-Chair[...]
Pr. Alexander Eggermont
Professor Alexander Eggermont has been Professor of Oncology with the status of «Classe Exceptionelle» in the Paris-Sud University since 2012 and Professor of Oncological Surgery at the Erasmus University of Rotterdam (Holland) since 2003. He also holds a Chair in the inte
Adel Al-Saleh
Before being appointed Member of the Board of Management of Deutsche Telekom AG and CEO of T-Systems effective January 1, 2018, Adel Al-Saleh was CEO of Northgate Information SolutionsGroup where he developed a turnaround strategy and drove a successful value[...]
Bernard Gilly, PhD
Mr. Bernard Gilly, Ph.D. has over twenty years of experience in the financial and biotech sectors.He co-founded several disruptive technologies start-ups and is currently Chairman of Pixium Vision(2011), EyeTechCare (2012), Gecko Biomedical (2013) and Chronocam (2015). From